Is Fulgent Genetics a Good Healthcare Stock to Buy?
While it's natural to track share prices of your favorite stocks, it's important to remember that price alone never indicates a good or bad stock. Shares of Fulgent Genetics (NASDAQ: FLGT) are down nearly 18% over the past week
This is despite the fact that the stock reported excellent third-quarter earnings on Nov. 9 with its core revenue up nearly 300% year over year and total revenue up 124% from the year-ago period.
In this segment of Backstage Pass, recorded on Nov. 5, Fool contributors Toby Bordelon and Rachel Warren respond to a viewer's question about the stock and its volatile share price lately.
Source Fool.com
